CURE241220C94000
- 0.00
- 0.000.00%
Direxion Daily Healthcare Bull 3X Shares Newsroom
Zevra Niemann-Pick Disease Type C Drug Miplyffa Now Available
Johnson & Johnson Announces Health Canada Authorizes CARVYKTI For Patients With Relapsed Or Refractory Multiple Myeloma Who Have Received 1-3 Prior Lines Of Therapy, Including A Proteasome Inhibitor And An Immunomodulatory Agent, And Who Are...
Shares Of Hims & Hers Health See Volume; Traders Circulate Court Filing Regarding Shortage Of Lilly's Tirzepatide Shortage, Parties Agree To Maintain Stay As Ordered By Court In October 2024, With Joint Status Report Due By December 19, 2024, Or...
Hims & Hers Closes up 10% as Lilly Tirzepatide Compounding Dispute Resolution Delayed
Optimism Over Global Healthcare Sector Rises: Jefferies
Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
Spotlight on Johnson & Johnson: Analyzing the Surge in Options Activity
Citi Research's U.S. Equity Strategy Large-Cap Recommendation List
Pyxis Stock Craters 46% Amid Phase 1 Data, William Blair Downgrade
Price Over Earnings Overview: Johnson & Johnson
Following the US Secretary of Health, Trump's nomination for the FDA Commissioner seems to be another anti-vaccine advocate.
Makari is a surgeon who opposes overtreatment, advocates for re-evaluating hormone replacement therapy, and reducing the overuse of antibiotics.
Pyxis Oncology Plummets 38% on Preliminary Phase 1 Data for Cancer Asset
Eli Lilly, Verge Genomics Opt To Develop ALS Drug Candidate
Eli Lilly in Pact With Chinese Biotech for Novel Weight Loss Therapy
U.S. CDC Says Flu, Covid-19, RSV Illnesses Are At Low Levels Right Now Overall In U.S., But We Expect Them To Increase In Coming Weeks; Expects Hospitalizations For Flu And Covid-19 To Start Increasing In Coming Weeks
Goldman's Hedge Fund VIP List: AMZN, VST, CRM, BABA, and More
Unpacking the Latest Options Trading Trends in AbbVie
Tectonic Started at Outperform by Raymond James, TX45 Cited
A former Federal Reserve governor is leading the pack as a popular candidate for treasury secretary, but can Trump's political views be accepted?
① The key candidates for Trump's cabinet are gradually being determined, but the selection for the Secretary of the Treasury remains undecided, raising market curiosity and anxiety; ② The possibility of former Federal Reserve Governor Kevin Walsh becoming the Secretary of the Treasury has rebounded, with his nomination probability reaching 49% at one point; ③ The market believes that Walsh's election could alleviate concerns about the cooperation between the Federal Reserve and the Treasury in providing government funding.
More Companies Covering Weight Loss Drugs for Their Employees